Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Larsen

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Chemico-Biological Interactions|February 16, 2024
Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymesCyrus Takahashi, Mikhail Chtcherbinine, Brandt C Huddle, et al.
Journal of Medicinal Chemistry|March 21, 2012
Novel inhibitors of neurotropic alphavirus replication that improve host survival in a mouse model of acute viral encephalitisJanice A Sindac, Bryan D Yestrepsky, Scott J Barraza, et al.
Journal of Lipid Research|November 8, 2011
Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brainScott D Larsen, Michael W Wilson, Akira Abe, et al.
Combinatorial Chemistry & High Throughput Screening|January 14, 2014
The role of HTS in drug discovery at the University of MichiganMartha J Larsen, Scott D Larsen, Andrew Fribley, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1BScott D Larsen, Tjeerd Barf, Charlotta Liljebris, et al.
Molecular Pharmacology|October 27, 2017
Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 InhibitorsRenee Bouley, Helen V Waldschmidt, M Claire Cato, et al.
Journal of Medicinal Chemistry|February 27, 2014
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteasesYahira M Báez-Santos, Scott J Barraza, Michael W Wilson, et al.
Digestive Diseases and Sciences|March 15, 2011
Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitisManabu Okawada, Hiroyuki Koga, Scott D Larsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2012
Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in miceHongmin Sun, Yuanxi Xu, Izabela Sitkiewicz, et al.
Scientific Reports|April 2, 2017
Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosisCynthia Yu-Wai-Man, Bradley Spencer-Dene, Richard M H Lee, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Chemico-Biological Interactions|February 16, 2024
Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymesCyrus Takahashi, Mikhail Chtcherbinine, Brandt C Huddle, et al.
Journal of Medicinal Chemistry|March 21, 2012
Novel inhibitors of neurotropic alphavirus replication that improve host survival in a mouse model of acute viral encephalitisJanice A Sindac, Bryan D Yestrepsky, Scott J Barraza, et al.
Journal of Lipid Research|November 8, 2011
Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brainScott D Larsen, Michael W Wilson, Akira Abe, et al.
Combinatorial Chemistry & High Throughput Screening|January 14, 2014
The role of HTS in drug discovery at the University of MichiganMartha J Larsen, Scott D Larsen, Andrew Fribley, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1BScott D Larsen, Tjeerd Barf, Charlotta Liljebris, et al.
Molecular Pharmacology|October 27, 2017
Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 InhibitorsRenee Bouley, Helen V Waldschmidt, M Claire Cato, et al.
Journal of Medicinal Chemistry|February 27, 2014
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteasesYahira M Báez-Santos, Scott J Barraza, Michael W Wilson, et al.
Digestive Diseases and Sciences|March 15, 2011
Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitisManabu Okawada, Hiroyuki Koga, Scott D Larsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2012
Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in miceHongmin Sun, Yuanxi Xu, Izabela Sitkiewicz, et al.
Scientific Reports|April 2, 2017
Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosisCynthia Yu-Wai-Man, Bradley Spencer-Dene, Richard M H Lee, et al.
Pageof 9